Back to search
FDAFDA · Food and drugs·Recall number D-1337-2015

Bi-Est 80:20 Progesterone (estriol,estradiol, progesterone) capsules, Rx only, Manufactured by Park Compounding, Irvine, CA

Published September 9, 2015 · Recall initiated: April 23, 2015

Summary

FDA records drug Class II recall D-1337-2015, published September 9, 2015 and initiated April 23, 2015. Recalling firm: South Coast Specialty Compounding, Inc.; Status: Terminated; Reported quantity: ALL LOTS; Lot: All Lots, Exp 09/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
South Coast Specialty Compounding, Inc.
Distributor
Nationwide.
Lot
All Lots, Exp 09/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bi-Est 80:20 Progesterone (estriol,estradiol, progesterone) capsules, Rx only, Manufactured by Park Compounding, Irvine, CA recalled?

Yes. FDA published recall D-1337-2015 on September 9, 2015. Reported hazard: Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

What should I do if I have this product?

Voluntary: Firm initiated · Letter